Risk of maculopathy with pentosan polysulfate sodium use
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15303
Abstract: Recent epidemiologic studies have examined the risk of maculopathy with pentosan polysulfate sodium (PPS), a drug indicated for the treatment of interstitial cystitis. However, results have been contradictory. Thus, we quantified the risk of maculopathy… read more here.
Keywords: polysulfate sodium; pentosan polysulfate; maculopathy pentosan; risk maculopathy ... See more keywords